G2 Bio Mourns the Passing of Chairman and Co-Founder Tachi Yamada, M.D.
August 05, 2021 14:35 ET
|
G2 Bio Management Company
PHILADELPHIA, Aug. 05, 2021 (GLOBE NEWSWIRE) -- G2 Bio Companies (G2 Bio Management Company, Inc., and affiliates) announce with great sadness the passing of co-founder and Chairman, Tadataka...
G2 Bio Companies Launch with US$200 Million to Develop Transformative Genetic-Based Therapies
May 18, 2021 07:00 ET
|
G2 Bio Management Company
- Partnership between University of Pennsylvania Gene Therapy Program, James Wilson, M.D., Ph.D., Tachi Yamada, M.D., and Temasek - US$200 million financing commitment from Temasek to fund...